These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 19405431)

  • 1. Upon closer inspection. As the U.S. imports more drugs and devices, the FDA's overseas initiatives aim to head off trouble at the source.
    Rhea S
    Mod Healthc; 2009 Mar; 39(13):28-30. PubMed ID: 19405431
    [No Abstract]   [Full Text] [Related]  

  • 2. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
    [No Abstract]   [Full Text] [Related]  

  • 4. Foreign establishment registration and listing. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(228):59138-61. PubMed ID: 11776289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutual recognition agreements and harmonization.
    Horton L
    Seton Hall Law Rev; 1998; 29(2):692-735. PubMed ID: 10569828
    [No Abstract]   [Full Text] [Related]  

  • 6. Transparent reaction. Suppliers oppose FDA move to disclose more data.
    Rhea S
    Mod Healthc; 2010 Jul; 40(30):16. PubMed ID: 20695055
    [No Abstract]   [Full Text] [Related]  

  • 7. The importance and challenges of "mutual recognition".
    Merrill RA
    Seton Hall Law Rev; 1998; 29(2):736-55. PubMed ID: 10569829
    [No Abstract]   [Full Text] [Related]  

  • 8. Enforcement policy: recalls (including product corrections)--guidelines on policy, procedures, and industry responsibilities.
    Fed Regist; 1978 Jun; 43(117):26201-21. PubMed ID: 10316619
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA's Quality System Inspection Technique in Ireland.
    Higgins S
    Med Device Technol; 2001; 12(1):40-1. PubMed ID: 11317865
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical devices; medical device reporting. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Feb; 70(38):9516-28. PubMed ID: 15736310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highlights and a hidden hazard--the FDA's new labeling regulations.
    Avorn J; Shrank W
    N Engl J Med; 2006 Jun; 354(23):2409-11. PubMed ID: 16760439
    [No Abstract]   [Full Text] [Related]  

  • 12. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 13. Is FDA's medical device evaluation process overly complaisant to industry?
    Margolis RE
    Healthspan; 1992; 9(7):19-20. PubMed ID: 10121440
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 15. The FDA's humanitarian device exemption program.
    Eydelman MB; Chen EA
    Health Aff (Millwood); 2011 Jun; 30(6):1210-2; author reply 1212. PubMed ID: 21653975
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of orphan products.
    Finkel MJ
    N Engl J Med; 1982 Oct; 307(15):963-4. PubMed ID: 7110287
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 18. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK
    Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555
    [No Abstract]   [Full Text] [Related]  

  • 20. Using the FDA's Device Experience Network.
    Collins JL
    Oncol Nurs Forum; 1992 Apr; 19(3):524. PubMed ID: 1594477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.